by Richard Daverman, PhD
October 2, 2013 -- Lee’s Pharmaceutical Holdings of Hong Kong reported that its China registration study of Trazodone as a treatment for depression met its primary endpoint. Lee’s in-licensed Trazodone (Trittico®) from Italian pharma Angelini. The Trazodone cohort of the trial showed a statistically significant improvement over placebo on a depression measurement scale. More details....
Stock Symbol: (HK: 0950)
Help employers find you! Check out all the jobs and post your resume.
